Skip to content

Public FDA record

Z-2501-2010: UCG Beta Slide Monoclonal II is a latex agglutination inhibition slide test for the detection of hCG in

Recall record Z-2501-2010 for Inverness Medical Professional Diagnostics. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2501-2010
Company in FDA record
Inverness Medical Professional Diagnostics
FDA classification date
Sep 25, 2010
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Specific lots no longer meet their stated limit of detection claims of 2000 mIU/mL for the UCG-Slide test and 500 mIU/mL for the UCG-Beta Slide Monoclonal II test.

Source facts

Action
The recall was initiated on February 12, 2010. Letters were sent by Fed Ex on 2/12/2010.
Initiated
2010-02-12
Root cause
Other
Terminated
2012-05-14
Distribution
Distributed Nationwide and to Australia
Recall number
Z-2501-2010
Recall status
Terminated
CDRH record ID
89150
FDA classified
2010-09-25
Recall event number
54745

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗